A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Resolution of steatohepatitis without worsening of fibrosis occurred in 62.9% of the 534 patients in the semaglutide group and in 34.3% of the 266 patients in the placebo group (estimated ...

The drug is based on a molecule called semaglutide, which mimics the structure of a naturally occurring ... of not consuming enough water, calories, protein and fiber," Tara Schmidt, Lead ...

“The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the ...

Inflammation was measured by levels of high-sensitivity C-reactive protein (CRP ... found that once weekly semaglutide (2.4mg) improved multiple domains of cardiac structure and cardiac function ...

The researchers found that based on 551 cases, there were an estimated 24,499 emergency department visits attributed to semaglutide adverse events in 2022 through 2023 (mean patient age, 50.9 ...